Research Identifies Black Licorice Compound as Potential Treatment for Inflammatory Bowel Disease
Researchers have identified glycyrrhizin, a natural compound found in black licorice, as a promising candidate for treating inflammatory bowel disease (IBD). The study, published in Stem Cell Reports, utilized a new stem cell-based model of the human intestine to test the compound's efficacy. IBD is a chronic condition characterized by persistent inflammation in the digestive tract, affecting millions globally. Current treatments often fail to provide lasting relief, prompting the need for new therapeutic approaches. The research team, led by Yu Takahashi at the University of Tokyo, developed a human intestine model using stem cells and induced an IBD-like condition by exposing the tissue to a major inflammatory protein. Glycyrrhizin emerged as a top candidate, significantly reducing intestinal cell death in the model and lowering inflammation levels in mice with IBD. 
